Jinxin Fertility Group Limited (abbreviation: JXR) filed a Next Day Disclosure Return on 31 March 2026 detailing the latest progress of its share repurchase programme on the Hong Kong Stock Exchange.

On 31 March 2026, the company bought back 1.96 million ordinary shares on-market at prices ranging from HKD 2.35 to HKD 2.37 per share. The total consideration paid was HKD 4.62 million. All shares repurchased will be cancelled.

Including this transaction, JXR has acquired 45.97 million shares under the current mandate approved on 26 June 2025, equivalent to 1.67% of the company’s issued share capital on the mandate date. The mandate authorises buybacks of up to 274.47 million shares, leaving 83% of the authorised quota unused. Repurchase prices recorded since December 2025 have ranged between HKD 2.29 and HKD 2.56 per share.

Share capital remained unchanged over the reporting period. As of 31 March 2026, JXR had 2.74 billion issued shares (excluding 13.00 million treasury shares), maintaining a total of 2.76 billion shares on issue.

Under Hong Kong listing rules, JXR is subject to a moratorium on new share issues or treasury-share disposals until 30 April 2026 following the latest repurchase.